Advertisement

Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry

      Abstract

      Study Aim

      Clinical guidelines recommend fibrinolysis or embolectomy for acute massive pulmonary embolism (PE) (MPE). However, actual therapy and outcomes of emergency department (ED) patients with MPE have not previously been reported. We characterize the current management of ED patients with MPE in a US registry.

      Methods

      A prospective, observational, multicenter registry of ED patients with confirmed PE was conducted from 2006 to 2008. Massive PE was defined as PE with an initial systolic blood pressure less than 90 mm Hg. We compared inpatient and 30-day mortality, bleeding complications, and recurrent venous thromboembolism.

      Results

      Of 1875 patients enrolled, 58 (3.1%) had MPE. There was no difference in frequency of parenteral anticoagulation (98.3% [95% confidence interval {CI}, 90.5-101.6] vs 98.5% [95% CI, 97.9-99.1], P = .902) between patients with and without MPE. Fibrinolytic therapy and embolectomy were infrequently used but were used more in patients with MPE than in patients without MPE (12.1% [95% CI, 3.7-20.5] vs 2.4% [95% CI, 1.7-3.1], P < .001, and 3.4% [95% CI, 0.0-8.1] vs 0.7% [95% CI, 0.3-1.1], P = .022, respectively). Comparison of outcomes revealed higher all-cause inpatient mortality (13.8% [95% CI, 4.9-22.7] vs 3.0% [95% CI, 2.2-3.8], P < .001), higher risk of inpatient bleeding complications (10.3% [95% CI, 2.5-18.1] vs 3.5% [95% CI, 2.7-4.3], P = .007), and a higher 30-day mortality (14.0% [95% CI, 4.4-23.6] vs 1.8% [95% CI, 1.2-2.4], P < .001) for patients with MPE.

      Conclusions

      In a contemporary registry of ED patients, MPE mortality was 4-fold higher than patients without MPE, yet only 12% of the MPE cohort received fibrinolytic therapy. Variability exists between the treatment of MPE and current recommendations.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D; use, select 'Corporate R&D; Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Torbicki A.
        • Perrier A.
        • Konstantinides S.
        • et al.
        Guidelines on the diagnostic and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).
        Eur Heart J. 2008; 29: 2226-2315
        • Tapson V.F.
        Acute pulmonary embolism.
        N Engl J Med. 2008; 358: 1037-1052
        • Goldhaber S.Z.
        • Visani L.
        • De Rosa M.
        Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).
        Lancet. 1999; 353: 1386-1389
        • Nijkeuter M.
        • Sohne M.
        • Tick L.W.
        • et al.
        The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study.
        Chest. 2007; 131: 517-523
        • van Strijen M.J.
        • de Monye W.
        • Schiereck J.
        • et al.
        Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients.
        Ann Intern Med. 2003; 138: 307-314
        • Perrier A.
        • Roy P.M.
        • Aujesky D.
        • et al.
        Diagnosing pulmonary embolism in outpatients with clinical assessment, d-dimer measurement, venous ultrasound and helical computed tomography: a multicenter management study.
        Am J Med. 2004; 116: 291-299
        • Kasper W.
        • Konstantinides S.
        • Geibel A.
        • et al.
        Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry.
        J Am Coll Cardiol. 1997; 30: 1165-1171
        • Laporte S.
        • Mismetti P.
        • Decousus H.
        • et al.
        Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.
        Circulation. 2008; 117: 1711-1716
        • Wan S.
        • Quinlan D.J.
        • Agnelli G.
        • Eikelboom J.W.
        Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
        Circulation. 2004; 110: 744-749
        • Konstantinides S.V.
        Massive pulmonary embolism: what level of aggression?.
        Semin Respir Crit Care Med. 2008; 29: 47-55
        • Kearon C.
        • Kahn S.R.
        • Agnelli G.
        • et al.
        Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
        Chest. 2008; 133: 454S-545S
        • British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group
        British Thoracic Society guidelines for the management of suspected pulmonary embolism.
        Thorax. 2003; 58: 470-483
        • Samoukovic G.
        • Malas T.
        • de Varennes B.
        The role of pulmonary embolectomy in the treatment of acute pulmonary embolism: a literature review from 1968 to 2008.
        Interact Cardiovasc Thorac Surg. 2010; 11: 265-270
        • Kucher N.
        • Rossi E.
        • De Rosa M.
        • Goldhaber S.Z.
        Massive pulmonary embolism.
        Circulation. 2006; 113: 577-582
        • Jaff M.R.
        • McMurtry S.
        • Archer S.L.
        • et al.
        Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
        Circulation. 2011; 123: 1788-1830
        • Fesmire F.M.
        • Brown M.D.
        • Espinosa J.A.
        • et al.
        Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism.
        Ann Emerg Med. 2011; 57: 628-652.e75
        • Agnelli G.
        • Becattini C.
        Acute pulmonary embolism.
        N Engl J Med. 2010; 363: 266-274
        • Pollack C.V.
        • Schreiber D.H.
        • Goldhaber S.Z.
        • et al.
        Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of the multicenter Emergency Medicine Pulmonary Embolism in the Real wOrld Registry (EMPEROR).
        J Am Coll Cardiol. 2011; 57: 700-706
        • Wells P.S.
        • Anderson D.R.
        • Rodger M.
        • et al.
        Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer.
        Ann Intern Med. 2001; 135: 98-107
        • Aujesky D.
        • Obrosky D.S.
        • Stone R.A.
        • et al.
        Derivation and validation of a prognostic model for pulmonary embolism.
        Am J Respir Crit Care Med. 2005; 172: 1041-1046
        • Aujesky D.
        • Perrier A.
        • Roy P.M.
        • et al.
        Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism.
        J Int Med. 2007; 261: 597-604
        • Donzé J.
        • Le Gal G.
        • Fine M.J.
        • et al.
        Prospective validation of the Pulmonary Embolism Severity Index: a clinical prognostic model for pulmonary embolism.
        Thromb Haemost. 2008; 100: 943-948
      1. The Urokinase Pulmonary Embolism Trial: a national cooperative study.
        Circulation. 1973; 47: 1-108
        • Ibrahim S.A.
        • Stone R.A.
        • Obrosky S.
        • Geng M.
        • Fine M.J.
        • Aujesky D.
        Thrombolytic therapy and mortality in patients with acute pulmonary embolism.
        Arch Int Med. 2008; 168: 2183-2190
        • Wilcox R.G.
        Thrombolysis with tissue plasminogen activator in suspected acute myocardial infarction. The ASSET Study.
        Chest. 1989; 95: 270S-275S
        • Stein P.D.
        • Hull R.D.
        • Raskob G.
        Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management.
        Ann Intern Med. 1994; 121: 313-317